in-house manufacturing capabilities gives cell and gene therapy developers a competitive advantage
Published 2 years ago • 72 plays • Length 57:04Download video MP4
Download video MP3
Similar videos
-
33:07
accelerate cell and gene therapy development and increase manufacturing capacity....
-
43:04
roundtable discussion: cell and gene therapies — keep the work in-house, or use a third party?
-
24:29
meeting regulatory requirements for cell and gene therapy manufacturing
-
19:04
the expanding dna and gene therapy market
-
57:23
feeding the demand for cell and gene therapy production
-
59:45
webinar: manufacturing challenges facing cell and gene therapy
-
20:34
technology-ready processes for gene therapy manufacturing 2.0
-
18:16
moving gene therapies to market: the role of manufacturing technologies
-
20:05
technology integrators in cell and gene therapy: powering innovation
-
2:23
cell and gene therapy manufacturing innovation
-
12:30
acoustic cell processing: an innovation in cell therapy manufacturing
-
10:03
advancing the development and manufacturing of cell and gene therapies
-
2:03
biocentriq cell & gene therapy process development and clinical manufacturing center
-
35:06
improving gene therapy viral vector manufacturing economics modelling bioprocess costs
-
1:26
what are the benefits of in-process control in cell therapy manufacturing processes ?
-
13:23
manufacturing automation for patient-scale cell therapies
-
17:12
development of an advanced gene therapy platform
-
48:34
modernize your gene therapy analytics with automated tools from bio techne